PIETRANGELO, Antonello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.960
EU - Europa 13.778
AS - Asia 11.638
SA - Sud America 1.811
AF - Africa 150
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 56.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.654
GB - Regno Unito 4.626
CN - Cina 4.348
SG - Singapore 3.254
IT - Italia 3.176
HK - Hong Kong 1.661
SE - Svezia 1.603
BR - Brasile 1.576
DE - Germania 1.118
UA - Ucraina 694
KR - Corea 679
FI - Finlandia 624
RU - Federazione Russa 585
TR - Turchia 471
VN - Vietnam 387
FR - Francia 362
BG - Bulgaria 293
CA - Canada 194
IN - India 182
ID - Indonesia 168
NL - Olanda 163
AR - Argentina 88
JP - Giappone 88
BD - Bangladesh 83
IE - Irlanda 73
BE - Belgio 69
MX - Messico 62
LT - Lituania 55
AT - Austria 54
MY - Malesia 53
PL - Polonia 52
AU - Australia 50
ZA - Sudafrica 48
ES - Italia 46
IQ - Iraq 41
RO - Romania 40
EC - Ecuador 37
CO - Colombia 35
IR - Iran 34
PK - Pakistan 34
CH - Svizzera 30
EG - Egitto 25
CZ - Repubblica Ceca 20
CL - Cile 18
MA - Marocco 17
VE - Venezuela 17
GR - Grecia 16
PE - Perù 15
UZ - Uzbekistan 15
AE - Emirati Arabi Uniti 14
IL - Israele 14
PY - Paraguay 14
SA - Arabia Saudita 13
PT - Portogallo 12
DZ - Algeria 11
HU - Ungheria 11
KE - Kenya 11
PH - Filippine 11
TW - Taiwan 11
EU - Europa 10
JM - Giamaica 10
AZ - Azerbaigian 9
OM - Oman 9
TN - Tunisia 9
TH - Thailandia 8
AL - Albania 7
BO - Bolivia 7
HN - Honduras 7
KZ - Kazakistan 7
RS - Serbia 7
SI - Slovenia 7
NP - Nepal 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
GE - Georgia 5
JO - Giordania 5
NO - Norvegia 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
DK - Danimarca 4
LK - Sri Lanka 4
LV - Lettonia 4
PA - Panama 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BY - Bielorussia 3
BZ - Belize 3
EE - Estonia 3
GT - Guatemala 3
HR - Croazia 3
NG - Nigeria 3
BF - Burkina Faso 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CM - Camerun 2
Totale 56.365
Salva come PNG Salva come JPEG
Città #
Fairfield 3.378
Southend 3.205
Santa Clara 2.748
Ashburn 2.390
Woodbridge 2.261
Singapore 1.894
Hefei 1.856
Chandler 1.794
Houston 1.778
Hong Kong 1.657
Jacksonville 1.382
Wilmington 1.145
Seattle 1.138
Cambridge 1.050
Ann Arbor 969
Dearborn 969
London 829
Nyköping 828
Seoul 637
Beijing 634
Modena 522
Chicago 460
Los Angeles 408
San Diego 366
Helsinki 339
Princeton 301
Dallas 297
Sofia 278
Eugene 235
New York 212
Izmir 201
Buffalo 193
Moscow 187
Milan 179
Shanghai 171
Munich 168
Des Moines 154
Rome 153
São Paulo 152
Redwood City 145
Council Bluffs 143
Jakarta 143
Bologna 131
Ho Chi Minh City 131
The Dalles 110
Hanoi 96
Columbus 90
Bremen 88
Salt Lake City 80
Falls Church 77
Parma 68
Brussels 62
Toronto 60
Yalova 60
Ottawa 59
Tokyo 59
Kent 58
Dublin 57
Philadelphia 52
Boardman 51
Phoenix 50
Nuremberg 48
Rio de Janeiro 48
Norwalk 47
Turku 45
Brooklyn 43
Florence 43
Fremont 43
Montreal 42
Nanjing 42
Redondo Beach 42
San Mateo 41
Guangzhou 40
Warsaw 40
Belo Horizonte 38
Elk Grove Village 38
Kilburn 38
San Francisco 38
Frankfurt am Main 36
Rimini 36
Amsterdam 35
Brasília 35
Verona 35
Tampa 34
Reggio Emilia 33
Stockholm 33
Kunming 32
Bari 30
Paris 28
Turin 28
Johannesburg 27
Dong Ket 26
Formigine 26
Guarulhos 26
Padova 25
Denver 24
Grafing 24
Jinan 24
Vienna 24
Boston 23
Totale 40.748
Salva come PNG Salva come JPEG
Nome #
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 622
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 369
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 368
Association between celiac disease and idiopathic dilated cardiomyopathy: a case report. 348
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 343
Coproporphyrin excretion in healthy newborn babies 341
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 335
Ferroportin disease: Pathogenesis, diagnosis and treatment 332
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 331
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 331
Non-HFE Hepatic Iron Overload. 330
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 322
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 308
Hereditary hemochromatosis--a new look at an old disease. 307
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene 307
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 304
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 298
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 296
Human macrophage ferroportin biology and the basis for the ferroportin disease 290
An unfortunate case of post-ERCP complications 289
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 287
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 283
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 281
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription 278
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 275
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 274
ER stress controls iron metabolism through induction of hepcidin. 272
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 272
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 270
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 269
Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: Evidence for a role in hepcidin induction by inflammation in male mice 268
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 267
VITAMIN-E SUPPLEMENTATION PREVENTS HEPATIC CIRRHOSIS DUE TO IRON OVERLOAD IN RODENTS 266
Haptoglobin modifies the hemochromatosis phenotype in mice 265
The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression 264
Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents 263
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 263
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 262
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 261
Heterogeneity of hemochromatosis in Italy 260
Duodenal ferritin synthesis in genetic hemochromatosis 260
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 259
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy 259
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 258
Primary hypoparathyroidism is common in adult patients with b-thalassemia and protect patients from osteoporosis. 258
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis. 257
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 254
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 254
3-hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo 253
MOLECULAR AND CELLULAR ASPECTS OF IRON-INDUCED HEPATIC CIRRHOSIS IN RODENTS 252
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 251
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 251
The impact of inherited thrombophilia on liver transplantation. 250
Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. 249
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion 248
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 247
Liver gene expression during chronic dietary iron overload in rats 247
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB 247
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 245
Lipid composition and fluidity of liver plasma membranes from rats with chronic dietary iron overload. 243
The SMAD pathway is required for hepcidin response during endoplasmic reticulum stress 243
Missed treatment in an Italian HBV infected patients cohort: HBV RER 243
Comorbidity does not mean clinical complexity: evidence from the RePoSI register 243
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 241
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 238
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 237
Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. 235
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 233
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload 231
Reducing the risk of hospital admission: A call to action from the Italian Society of Internal Medicine 231
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 230
Diacerhein blocks iron regulatory protein activation in inflamed human monocytes 229
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis 229
DNA repair in lymphocytes from humans and rats with chronic iron overload. 228
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 228
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 228
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 228
Antioxidant activity of silybin in vivo during long-term iron overload in rats 227
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene 227
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 226
Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years since Hepcidin 226
Thyroid volume in adult beta-thalassemic patients is smaller than in controls 224
The penetrance of hemochromatosis: mice to the rescue. 223
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 222
Disease progression and liver cancer in the ferroportin disease 220
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment 220
Haemochromatosis 220
Lack of enterocyte iron accumulation in the ferroportin disease 219
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 217
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 217
Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum 216
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 215
EASL International Concensus Conference on Hepatitis B - 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version) 213
Iron and steatohepatitis. 212
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 211
Iron, friend or foe? "Freedom" makes the difference 211
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 211
Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis 210
Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? 210
Iron chelation beyond transfusion iron overload 209
Totale 26.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.917 0 0 0 0 830 614 775 825 271 685 496 421
2021/20225.494 284 581 517 380 223 271 393 295 619 436 861 634
2022/20235.388 612 563 348 504 647 824 114 592 645 86 244 209
2023/20243.601 169 221 511 298 529 273 301 425 133 188 192 361
2024/202512.875 675 150 341 856 2.182 1.813 773 698 1.227 768 1.768 1.624
2025/20268.087 1.709 1.253 2.283 2.289 553 0 0 0 0 0 0 0
Totale 56.803